ramirez I, Vera Z, Mastroianni P, et al. Benefits of a National Program for Adverse Drugs Reactions (ADRS) Surveillance in Diabetic Patients. J. Drug Delivery Ther. 2022;12(4-S):40-42. doi:10.22270/jddt.v12i4-S.5618